HIVACCINE Trademark

Trademark Overview


On Thursday, July 4, 2002, a trademark application was filed for HIVACCINE with the United States Patent and Trademark Office. The USPTO has given the HIVACCINE trademark a serial number of 78141396. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 14, 2004. The HIVACCINE trademark is filed in the Pharmaceutical Products category with the following description:

vaccines and anti-viral drugs
hivaccine

General Information


Serial Number78141396
Word MarkHIVACCINE
Filing DateThursday, July 4, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 14, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the style use of HIV and HIVACCINE with or without a "TM" superscript.
Goods and Servicesvaccines and anti-viral drugs
Pseudo MarkHIV VACCINE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 10, 2002
Primary Code005
First Use Anywhere DateMonday, December 10, 2001
First Use In Commerce DateSunday, July 4, 2004

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSan Francisco, CA 94122

Trademark Events


Event DateEvent Description
Wednesday, January 14, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 23, 2003FINAL REFUSAL E-MAILED
Monday, April 7, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 30, 2002NON-FINAL ACTION E-MAILED
Wednesday, November 13, 2002ASSIGNED TO EXAMINER

Related Keywords


hivaccine drugs viral anti vaccines